期刊文献+

丹参酮ⅡA对兔动脉粥样硬化斑块胶原含量的影响 被引量:3

Effects of tanshinone ⅡA on stability of rabbit atherosclerotic plaques
原文传递
导出
摘要 目的:观察丹参酮ⅡA对兔动脉粥样硬化斑块胶原含量的影响,并对其机制进行初步探讨。方法:日本大耳兔随机分为对照组和丹参酮ⅡA(7、20、60mg/kg)4组,高胆固醇饮食10周建立兔动脉粥样硬化(atherosc lerosis,AS)病变模型后药物干预4周,取主动脉内膜组织分别采用W oessner方法、免疫组织化学方法和realtim e RT-PCR法检测斑块组织中胶原含量,MMP-1蛋白,IL-10、IL-1 mRNA表达,W estern-b lot方法检测斑块组织中PPAR-γ蛋白表达。结果:丹参酮ⅡA低剂量能明显提高斑块中胶原蛋白含量、PPAR-γ蛋白和IL-10 mRNA表达,明显降低斑块组织中MMP-1和IL-1 mRNA的表达;中、高剂量组能显著提高斑块中胶原蛋白含量、PPAR-γ蛋白和IL-10 mRNA表达,显著降低斑块组织中MMP-1和IL-1 mRNA的表达。结论:丹参酮ⅡA能提高动脉粥样硬化斑块中胶原蛋白含量,其机制可能与抑制炎症反应,降低MMP-1表达有关。 Aim: The instability of atherosclerosis plaque was the critical factor induced the heart events,and valid remedies for this were deficient at present.Rabbit atherosclerotic models were set up to study effects of Tanshinone ⅡA on stability of atherosclerotic plaques and initial investigation for mechanism.Method: Rabbit atherosclerotic models were set up by hypercholestermia diet.Contents of matrix metalloproteinase-1 and collagen in plaque were detected by immunohistochemical and woessner method,respectively.contents of metalloproteinase-1 protein were measured by Image Pro Plus 4.5.Expression levels of interleukin 6,interleukin-10 mRNA and peroxisome Proliferator-activated receptor gamma protein were determined with real-time PCR and western blot method,respectively.Result: In Tanshinone ⅡA groups,collagen,Proliferator-activated receptor gamma protein and interleukin 10 mRNA was elevated markedly,interleukin 6 mRNA and MMP-1 protein found in Tanshinone ⅡA groups were decreased.Conclusion: Tanshinone ⅡA could enhance stability of rabbit atherosclerotic plaque.This maybe be concerned with its anti-inflammatory action.
出处 《中药药理与临床》 CAS CSCD 北大核心 2009年第5期20-22,共3页 Pharmacology and Clinics of Chinese Materia Medica
关键词 丹参酮ⅡA 动脉粥样硬化 PPAR-Γ 白细胞介素-10 白细胞介素-6 基质金属蛋白酶-1 tanshinone ⅡA atherosclerosis peroxisome Proliferator-activated receptor interleukin 6 interleukin-10 metalloproteinase-1
  • 相关文献

参考文献8

  • 1周志斌,郭毅.不稳定性动脉粥样硬化斑块的特点及主要形成机制[J].国外医学(脑血管疾病分册),2004,12(2):137-140. 被引量:27
  • 2Viles-Gonzalez JF, Fuster V, Badimon JJ. Links between inflammation and thrombogenicity in atherosclerosis . Curr Mol Med, 2006, 6 (5): 489 - 499.
  • 3永井裕,藤本大三郎.刘平,译.胶原蛋白实验方法.上海中医学院出版社,1992:51-52.
  • 4van der Ploeg JR, Giertsen E, Ltldin B, et al. Quantitative detection of Porphyromonas gingivalis fimA genotypes in dental plaque. FEMS Mierobiol Lett, 2004,232 (1): 31 -37.
  • 5Tangirala RK, Rubin W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. Lipid Res, 1995 ,36 ( 11 ) : 2320 - 2328.
  • 6Kaplan JM, Cook JA, Hake PW, et al. 15-Deoxy-Delta ( 12, 14)-prostaglandin J2 ( 15D-PGJ2 ), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock . Shock, 2005,24 (1): 59-65.
  • 7Orbe J, Fernandez L, Rodriguez JA, et al. Different expression of MMPs/TIMP-1 in human atherosclerotie lesions. Relation to plaque features and vascular bed . Atherosclerosis, 2003 , 170(2) : 269 - 276.
  • 8Ge J, Chifillo F, Sehwedtmann J, et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound . Heart, 1999, 81(6): 621 -627.

二级参考文献19

  • 1Mason DP, Kenagy RD, Hasenstab D, et al. Matrix metalloproteinase-9 overexpression enhances vascular smooth muscle cell migration and alters remodeling in the injured rat carotid artery. Circ Res,1999, 85:1179 - 1185.?A
  • 2Schonbeck U, Mach F, Sukhova GK, et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ Res, 1997, 81: 448 -454.?A
  • 3Rouis M, Adamy C, Duverger N, et al. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprutein E-deficient mice. Circulation,1999, 100:533 -540.
  • 4Marx N, Sukhova G, Murphy C, et al. Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro. Am J Pathol, 1998, 153:17-23.?A
  • 5Geng YJ, Wu Q, Muszynski M, et al. Apoptosis of vascular smooth muscle cells induced by in vitro stinulation with interferon-gamma,tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler Thromb Vasc Biol, 1996, 16:19-27.?A
  • 6Libby P, Aikawa M. New iosights into plaque stabilisation by lipid lowering. Drugs, 1998, 56(Suppl 1 ): 9 - 13.?A
  • 7Plutzky J. Atherosclerotic plaque rupture: emerging insights and opportunities. Am J Cardiol, 1999, 84(1A): 15J -20J.?A
  • 8Loftus IM, Naylor AR, Goodall S, et al. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption. Stroke, 2000, 31:40 -47.?A
  • 9Newby AC, Zaltsman AB. Fibrous cap formation or destruction-the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc Res, 1999, 41:345 -360.?A
  • 10Kristensen SD, Ravn HB, Falk E. Insights into the pathophysioiogy of unstable coronary artery disease. Am J Cardiol, 1997, 80(5A):5E -9E.?A

共引文献26

同被引文献81

引证文献3

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部